Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1984 Oct;52(1):183–187. doi: 10.1128/jvi.52.1.183-187.1984

pppA2'p5A' blocks vesicular stomatitis virus replication in intact cells.

B Alarcon, H Bugany, L Carrasco
PMCID: PMC254504  PMID: 6090695

Abstract

pppA2'p5'A blocked the production of infectious vesicular stomatitis virus in HeLa cells. When this compound was present from the beginning of infection, a selective inhibitory effect was observed in viral protein synthesis. Thus, cellular translation was not affected even after 10 h of incubation with this compound, and the bulk of viral proteins was not synthesized. However, this effect was not observed with ATP, GTP, or the core A2'p5'A. The step blocked by pppA2'p5'A is located early during virus infection, but adsorption, entry, and virus uncoating seemed to be unaffected by this compound. Analysis of the antiviral spectrum of pppA2'p5'A indicated that it is active against poliovirus, encephalomyocarditis virus, and Semliki Forest virus and shows no effect against herpes simplex virus type 1 and adenovirus type 5.

Full text

PDF
183

Images in this article

185Image
on p.185
185Image
on p.185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baglioni C., Minks M. A., Maroney P. A. Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A. Nature. 1978 Jun 22;273(5664):684–687. doi: 10.1038/273684a0. [DOI] [PubMed] [Google Scholar]
  2. Bugany H., Bosch J. V., Ferdinand F. J., Friis R. R. Inhibition of Rous sarcoma virus assembly by treatment with 2',5' adenosine nucleotides. Virology. 1983 Jun;127(2):290–298. doi: 10.1016/0042-6822(83)90144-7. [DOI] [PubMed] [Google Scholar]
  3. Carrasco L., Lacal J. C. Permeabilization of cells during animal virus infection. Pharmacol Ther. 1983;23(1):109–145. doi: 10.1016/0163-7258(83)90028-1. [DOI] [PubMed] [Google Scholar]
  4. Clemens M. J., Williams B. R. Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell. 1978 Mar;13(3):565–572. doi: 10.1016/0092-8674(78)90329-x. [DOI] [PubMed] [Google Scholar]
  5. Devash Y., Biggs S., Sela I. Multiplication of tobacco mosaic virus in tobacco leaf disks is inhibited by (2'-5) oligoadenylate. Science. 1982 Jun 25;216(4553):1415–1416. doi: 10.1126/science.6178155. [DOI] [PubMed] [Google Scholar]
  6. Eppstein D. A., Barnett J. W., Marsh Y. V., Gosselin G., Imbach J. L. Xyloadenosine analogue of (A2'p)2A inhibits replication of herpes simplex viruses 1 and 2. Nature. 1983 Apr 21;302(5910):723–724. doi: 10.1038/302723a0. [DOI] [PubMed] [Google Scholar]
  7. Eppstein D. A., March Y. V., Schryver B. B., Larsen M. A., Barnett J. W., Verheyden J. P., Prisbe E. J. Analogs of (A2'p)nA. Correlation of structure of analogs of ppp(A2'p)2A and (A2'p)2A with stability and biological activity. J Biol Chem. 1982 Nov 25;257(22):13390–13397. [PubMed] [Google Scholar]
  8. Eppstein D. A., Marsh Y. V., Schryver B. B. Mechanism of antiviral activity of (XyloA2'p)2XyloA. Virology. 1983 Dec;131(2):341–354. doi: 10.1016/0042-6822(83)90502-0. [DOI] [PubMed] [Google Scholar]
  9. Goswami B. B., Crea R., Van Boom J. H., Sharma O. K. 2'-5'-Linked oligo(adenylic acid) and its analogs. A new class of inhibitors of mRNA methylation. J Biol Chem. 1982 Jun 25;257(12):6867–6870. [PubMed] [Google Scholar]
  10. Haugh M. C., Cayley P. J., Serafinowska H. T., Norman D. G., Reese C. B., Kerr I. M. Analogues and analogue inhibitors of ppp(A2'p)nA. Their stability and biological activity. Eur J Biochem. 1983 Apr 15;132(1):77–84. doi: 10.1111/j.1432-1033.1983.tb07327.x. [DOI] [PubMed] [Google Scholar]
  11. Henderson E. E., Doetsch P. W., Charubala R., Pfleiderer W., Suhadolnik R. J. Inhibition of Epstein-Barr virus-associated nuclear antigen (EBNA) induction by (2',5')oligoadenylate and the cordycepin analog: mechanism of action for inhibition of EBV-induced transformation. Virology. 1982 Oct 15;122(1):198–201. doi: 10.1016/0042-6822(82)90389-0. [DOI] [PubMed] [Google Scholar]
  12. Hovanessian A. G., Brown R. E., Kerr I. M. Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature. 1977 Aug 11;268(5620):537–540. doi: 10.1038/268537a0. [DOI] [PubMed] [Google Scholar]
  13. Hovanessian A. G., Wood J. N. Anticellular and antiviral effects of pppA(2'p5'A)n. Virology. 1980 Feb;101(1):81–90. doi: 10.1016/0042-6822(80)90485-7. [DOI] [PubMed] [Google Scholar]
  14. Hovanessian A. G., Wood J., Meurs E., Montagnier L. Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3261–3265. doi: 10.1073/pnas.76.7.3261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hughes B. G., Srivastava P. C., Muse D. D., Robins R. K. 2',5'-Oligoadenylates and related 2',5'-oligonucleotide analogues. 1. Substrate specificity of the interferon-induced murine 2',5'-oligoadenylate synthetase and enzymatic synthesis of oligomers. Biochemistry. 1983 Apr 26;22(9):2116–2126. doi: 10.1021/bi00278a011. [DOI] [PubMed] [Google Scholar]
  16. Jurovcík M., Smrt J. Inhibition of protein synthesis by exogenous A2'p5'A2'p5'A (2-5 A core) and its bis-phosphoramidate analog in intact mouse lymphocytes, hepatocytes and bone marrow cells. FEBS Lett. 1981 Oct 12;133(1):178–180. doi: 10.1016/0014-5793(81)80499-1. [DOI] [PubMed] [Google Scholar]
  17. Kerr I. M., Brown R. E. pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A. 1978 Jan;75(1):256–260. doi: 10.1073/pnas.75.1.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kimchi A., Shure H., Lapidot Y., Rapoport S., Panet A., Revel M. Antimitogenic effects of interferon and (2'-5')-oligoadenylate in synchronized 3T3 fibroblasts. FEBS Lett. 1981 Nov 16;134(2):212–216. doi: 10.1016/0014-5793(81)80604-7. [DOI] [PubMed] [Google Scholar]
  19. Kimchi A., Shure H., Revel M. Regulation of lymphocyte mitogenesis by (2'--5') oligo-isoadenylate. Nature. 1979 Dec 20;282(5741):849–851. doi: 10.1038/282849a0. [DOI] [PubMed] [Google Scholar]
  20. Masters P. S., Samuel C. E. Mechanism of interferon action: inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human leukocyte interferon. I. Effect on early and late stages of the viral multiplication cycle. J Biol Chem. 1983 Oct 10;258(19):12019–12025. [PubMed] [Google Scholar]
  21. Schmidt A., Zilberstein A., Shulman L., Federman P., Berissi H., Revel M. Interferon action: isolation of nuclease F, a translation inhibitor activated by interferon-induced (2'-5') oligo-isoadenylate. FEBS Lett. 1978 Nov 15;95(2):257–264. doi: 10.1016/0014-5793(78)81006-0. [DOI] [PubMed] [Google Scholar]
  22. Williams B. R., Kerr I. M. Inhibition of protein synthesis by 2'-5' linked adenine oligonucleotides in intact cells. Nature. 1978 Nov 2;276(5683):88–90. doi: 10.1038/276088a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES